<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">37505636</PMID><DateRevised><Year>2023</Year><Month>08</Month><Day>01</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2414-6366</ISSN><JournalIssue CitedMedium="Internet"><Volume>8</Volume><Issue>7</Issue><PubDate><Year>2023</Year><Month>Jun</Month><Day>25</Day></PubDate></JournalIssue><Title>Tropical medicine and infectious disease</Title><ISOAbbreviation>Trop Med Infect Dis</ISOAbbreviation></Journal><ArticleTitle>Clinical Evolution and Risk Factors in Patients Infected during the First Wave of COVID-19: A Two-Year Longitudinal Study.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">340</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/tropicalmed8070340</ELocationID><Abstract><AbstractText>A limited number of longitudinal studies have examined the symptoms associated with long-COVID-19. We conducted an assessment of symptom onset, severity and patient recovery, and determined the percentage of patients who experienced reinfection up to 2 years after the initial onset of the disease. Our cohort comprises 377 patients (&#x2265;18 years) with laboratory-confirmed COVID-19 in a secondary hospital (Madrid, Spain), throughout March 3-16, 2020. Disease outcomes and clinical data were followed-up until August 12, 2022. We reviewed the evolution of the 253 patients who had survived as of April 2020 (67.1%). Nine died between April 2020 and August 2022. A multivariate regression analysis performed to detect the risk factors associated with long-COVID-19 revealed that the increased likelihood was associated with chronic obstructive lung disease (OR 14.35, 95% CI 1.89-109.09; <i>p</i> = 0.010), dyspnea (5.02, 1.02-24.75; <i>p</i> = 0.048), higher LDH (3.23, 1.34-7.52; <i>p</i> = 0.006), and lower D-dimer levels (0.164, 0.04-0.678; <i>p</i> = 0.012). Reinfected patients (<i>n</i> = 45) (47.8 years; 39.7-67.2) were younger than non-reinfected patients (64.1 years; 48.6-74.4)) (<i>p</i> &lt; 0.001). Patients who received a combination of vaccines exhibited fewer symptoms (44.4%) compared to those who received a single type of vaccine (77.8%) (<i>p</i> = 0.048). Long-COVID-19 was detected in 27.05% (66/244) of patients. The early detection of risk factors helps predict the clinical course of patients with COVID-19. Middle-aged adults could be susceptible to reinfection, highlighting the importance of prevention and control measures regardless of vaccination status.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Rescalvo-Casas</LastName><ForeName>Carlos</ForeName><Initials>C</Initials><Identifier Source="ORCID">0000-0003-3745-6661</Identifier><AffiliationInfo><Affiliation>Departamento de Biomedicina y Biotecnolog&#xed;a, Facultad de Medicina, Universidad de Alcal&#xe1;, 28805 Madrid, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Departamento de Microbiolog&#xed;a Cl&#xed;nica, Hospital Universitario Pr&#xed;ncipe de Asturias, 28805 Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>P&#xe9;rez-Tanoira</LastName><ForeName>Ram&#xf3;n</ForeName><Initials>R</Initials><Identifier Source="ORCID">0000-0002-9816-3208</Identifier><AffiliationInfo><Affiliation>Departamento de Biomedicina y Biotecnolog&#xed;a, Facultad de Medicina, Universidad de Alcal&#xe1;, 28805 Madrid, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Departamento de Microbiolog&#xed;a Cl&#xed;nica, Hospital Universitario Pr&#xed;ncipe de Asturias, 28805 Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Villegas</LastName><ForeName>Roc&#xed;o Fern&#xe1;ndez</ForeName><Initials>RF</Initials><AffiliationInfo><Affiliation>Departamento de Biomedicina y Biotecnolog&#xed;a, Facultad de Medicina, Universidad de Alcal&#xe1;, 28805 Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hernando-Gozalo</LastName><ForeName>Marcos</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0003-2838-7270</Identifier><AffiliationInfo><Affiliation>Departamento de Microbiolog&#xed;a Cl&#xed;nica, Hospital Universitario Pr&#xed;ncipe de Asturias, 28805 Madrid, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Departamento de Qu&#xed;mica Org&#xe1;nica y Qu&#xed;mica Inorg&#xe1;nica, Facultad de Qu&#xed;mica, Universidad de Alcal&#xe1; de Henares, 28805 Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Seijas-Pereda</LastName><ForeName>Laura</ForeName><Initials>L</Initials><Identifier Source="ORCID">0000-0001-9360-7159</Identifier><AffiliationInfo><Affiliation>Departamento de Biomedicina y Biotecnolog&#xed;a, Facultad de Medicina, Universidad de Alcal&#xe1;, 28805 Madrid, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Departamento de Microbiolog&#xed;a Cl&#xed;nica, Hospital Universitario Pr&#xed;ncipe de Asturias, 28805 Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>P&#xe9;rez-Garc&#xed;a</LastName><ForeName>Felipe</ForeName><Initials>F</Initials><Identifier Source="ORCID">0000-0002-4885-4334</Identifier><AffiliationInfo><Affiliation>Departamento de Biomedicina y Biotecnolog&#xed;a, Facultad de Medicina, Universidad de Alcal&#xe1;, 28805 Madrid, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Departamento de Microbiolog&#xed;a Cl&#xed;nica, Hospital Universitario Pr&#xed;ncipe de Asturias, 28805 Madrid, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Centro de Investigaci&#xf3;n Biom&#xe9;dica en Red en Enfermedades Infecciosas (CIBERINFEC), Instituto de Salud Carlos III, 28029 Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mor&#xed;&#xf1;igo</LastName><ForeName>Helena Moza</ForeName><Initials>HM</Initials><AffiliationInfo><Affiliation>Departamento de Medicina Preventiva y Salud P&#xfa;blica, Hospital Universitario Fundaci&#xf3;n Jim&#xe9;nez D&#xed;az, 28040 Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>G&#xf3;mez-Herruz</LastName><ForeName>Pe&#xf1;a</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Departamento de Microbiolog&#xed;a Cl&#xed;nica, Hospital Universitario Pr&#xed;ncipe de Asturias, 28805 Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Arroyo</LastName><ForeName>Teresa</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Departamento de Microbiolog&#xed;a Cl&#xed;nica, Hospital Universitario Pr&#xed;ncipe de Asturias, 28805 Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gonz&#xe1;lez</LastName><ForeName>Rosa</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Departamento de Microbiolog&#xed;a Cl&#xed;nica, Hospital Universitario Pr&#xed;ncipe de Asturias, 28805 Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Exp&#xf3;sito</LastName><ForeName>Cristina Verd&#xfa;</ForeName><Initials>CV</Initials><Identifier Source="ORCID">0000-0002-3005-9244</Identifier><AffiliationInfo><Affiliation>Departamento de Biomedicina y Biotecnolog&#xed;a, Facultad de Medicina, Universidad de Alcal&#xe1;, 28805 Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lled&#xf3; Garc&#xed;a</LastName><ForeName>Lourdes</ForeName><Initials>L</Initials><Identifier Source="ORCID">0000-0001-5387-6792</Identifier><AffiliationInfo><Affiliation>Departamento de Biomedicina y Biotecnolog&#xed;a, Facultad de Medicina, Universidad de Alcal&#xe1;, 28805 Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cabrera</LastName><ForeName>Juan Romanyk</ForeName><Initials>JR</Initials><Identifier Source="ORCID">0000-0002-0067-1707</Identifier><AffiliationInfo><Affiliation>Departamento de Biomedicina y Biotecnolog&#xed;a, Facultad de Medicina, Universidad de Alcal&#xe1;, 28805 Madrid, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Departamento de Microbiolog&#xed;a Cl&#xed;nica, Hospital Universitario Pr&#xed;ncipe de Asturias, 28805 Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cuadros-Gonz&#xe1;lez</LastName><ForeName>Juan</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Departamento de Biomedicina y Biotecnolog&#xed;a, Facultad de Medicina, Universidad de Alcal&#xe1;, 28805 Madrid, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Departamento de Microbiolog&#xed;a Cl&#xed;nica, Hospital Universitario Pr&#xed;ncipe de Asturias, 28805 Madrid, Spain.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>DIABECOV-CM</GrantID><Agency>Community of Madrid with European Union funds against the COVID-19 pandemic</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>06</Month><Day>25</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Trop Med Infect Dis</MedlineTA><NlmUniqueID>101709042</NlmUniqueID><ISSNLinking>2414-6366</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">SARS-CoV-2</Keyword><Keyword MajorTopicYN="N">coronavirus disease 2019</Keyword><Keyword MajorTopicYN="N">long-COVID-19</Keyword><Keyword MajorTopicYN="N">reinfection</Keyword><Keyword MajorTopicYN="N">risk factors</Keyword><Keyword MajorTopicYN="N">vaccines</Keyword></KeywordList><CoiStatement>The authors declare that they have no conflict of interest. The funders had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript; or in the decision to publish the results.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>5</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>6</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>6</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>7</Month><Day>28</Day><Hour>13</Hour><Minute>12</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>7</Month><Day>28</Day><Hour>13</Hour><Minute>11</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>7</Month><Day>28</Day><Hour>11</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>6</Month><Day>25</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37505636</ArticleId><ArticleId IdType="pmc">PMC10384910</ArticleId><ArticleId IdType="doi">10.3390/tropicalmed8070340</ArticleId><ArticleId IdType="pii">tropicalmed8070340</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>2019-Nuevo Coronavirus.  [(accessed on 12 August 2022)].  Available online:  https://www.comunidad.madrid/servicios/salud/coronavirus.</Citation></Reference><Reference><Citation>Franco J.V.A., Garegnani L.I., Oltra G.V., Metzendorf M.-I., Trivisonno L.F., Sgarbossa N., Ducks D., Heldt K., Mumm R., Barnes B., et al. Long-Term Health Symptoms and Sequelae Following SARS-CoV-2 Infection: An Evidence Map. Int. J. Environ. Res. Public Health. 2022;19:9915. doi: 10.3390/ijerph19169915.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijerph19169915</ArticleId><ArticleId IdType="pmc">PMC9408764</ArticleId><ArticleId IdType="pubmed">36011562</ArticleId></ArticleIdList></Reference><Reference><Citation>Lopez-Leon S., Wegman-Ostrosky T., Perelman C., Sepulveda R., Rebolledo P.A., Cuapio A., Villapol S. More than 50 Long-Term Effects of COVID-19: A Systematic Review and Meta-Analysis. Sci. Rep. 2021;11:16144. doi: 10.1038/s41598-021-95565-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-021-95565-8</ArticleId><ArticleId IdType="pmc">PMC8352980</ArticleId><ArticleId IdType="pubmed">34373540</ArticleId></ArticleIdList></Reference><Reference><Citation>Desai A.D., Lavelle M., Boursiquot B.C., Wan E.Y. Long-Term Complications of COVID-19. Am. J. Physiol. Cell Physiol. 2022;322:C1&#x2013;C11. doi: 10.1152/ajpcell.00375.2021.</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/ajpcell.00375.2021</ArticleId><ArticleId IdType="pmc">PMC8721906</ArticleId><ArticleId IdType="pubmed">34817268</ArticleId></ArticleIdList></Reference><Reference><Citation>Aul D.R., Gates D.J., Draper D.A., Dunleavy D.A., Ruickbie D.S., Meredith D.H., Walters D.N., van Zeller D.C., Taylor D.V., Bridgett D.M., et al. Complications after Discharge with COVID-19 Infection and Risk Factors Associated with Development of Post-COVID Pulmonary Fibrosis. Respir. Med. 2021;188:106602. doi: 10.1016/j.rmed.2021.106602.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.rmed.2021.106602</ArticleId><ArticleId IdType="pmc">PMC8425673</ArticleId><ArticleId IdType="pubmed">34536697</ArticleId></ArticleIdList></Reference><Reference><Citation>Logue J.K., Franko N.M., McCulloch D.J., McDonald D., Magedson A., Wolf C.R., Chu H.Y. Sequelae in Adults at 6 Months after COVID-19 Infection. JAMA Netw. Open. 2021;4:e210830. doi: 10.1001/jamanetworkopen.2021.0830.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2021.0830</ArticleId><ArticleId IdType="pmc">PMC7896197</ArticleId><ArticleId IdType="pubmed">33606031</ArticleId></ArticleIdList></Reference><Reference><Citation>Sudre C.H., Murray B., Varsavsky T., Graham M.S., Penfold R.S., Bowyer R.C., Pujol J.C., Klaser K., Antonelli M., Canas L.S., et al. Attributes and Predictors of Long COVID. Nat. Med. 2021;27:626&#x2013;631. doi: 10.1038/s41591-021-01292-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-021-01292-y</ArticleId><ArticleId IdType="pmc">PMC7611399</ArticleId><ArticleId IdType="pubmed">33692530</ArticleId></ArticleIdList></Reference><Reference><Citation>Barshikar S., Laguerre M., Gordon P., Lopez M. Integrated Care Models for Long Coronavirus Disease. Phys. Med. Rehabil. Clin. N. Am. 2023 doi: 10.1016/j.pmr.2023.03.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.pmr.2023.03.007</ArticleId><ArticleId IdType="pmc">PMC10165471</ArticleId><ArticleId IdType="pubmed">37419540</ArticleId></ArticleIdList></Reference><Reference><Citation>Hall V., Foulkes S., Insalata F., Kirwan P., Saei A., Atti A., Wellington E., Khawam J., Munro K., Cole M., et al. Protection against SARS-CoV-2 after COVID-19 Vaccination and Previous Infection. N. Engl. J. Med. 2022;386:1207&#x2013;1220. doi: 10.1056/NEJMoa2118691.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa2118691</ArticleId><ArticleId IdType="pmc">PMC8908850</ArticleId><ArticleId IdType="pubmed">35172051</ArticleId></ArticleIdList></Reference><Reference><Citation>Rabaan A.A., Al-Ahmed S.H., Al Mutair A., Alhumaid S., Sule A.A., Tirupathi R., Fawzy M., Muhammad J., Khan A., Hasan A., et al. Immunopathogenesis and immunobiology of SARS-CoV-2. Le Infez. Med. 2021;29:167&#x2013;180.</Citation><ArticleIdList><ArticleId IdType="pubmed">34061781</ArticleId></ArticleIdList></Reference><Reference><Citation>Tao K., Tzou P.L., Nouhin J., Gupta R.K., de Oliveira T., Pond S.L.K., Fera D., Shafer R.W. The Biological and Clinical Significance of Emerging SARS-CoV-2 Variants. Nat. Rev. Genet. 2021;22:757&#x2013;773. doi: 10.1038/s41576-021-00408-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41576-021-00408-x</ArticleId><ArticleId IdType="pmc">PMC8447121</ArticleId><ArticleId IdType="pubmed">34535792</ArticleId></ArticleIdList></Reference><Reference><Citation>Nguyen N.N., Houhamdi L., Hoang V.T., Delerce J., Delorme L., Colson P., Brouqui P., Fournier P.-E., Raoult D., Gautret P. SARS-CoV-2 Reinfection and COVID-19 Severity. Emerg. Microbes Infect. 2022;11:894&#x2013;901. doi: 10.1080/22221751.2022.2052358.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/22221751.2022.2052358</ArticleId><ArticleId IdType="pmc">PMC8942490</ArticleId><ArticleId IdType="pubmed">35264078</ArticleId></ArticleIdList></Reference><Reference><Citation>Guan W., Ni Z., Hu Y., Liang W., Ou C., He J., Liu L., Shan H., Lei C., Hui D.S.C., et al. Clinical Characteristics of Coronavirus Disease 2019 in China. N. Engl. J. Med. 2020;382:1708&#x2013;1720. doi: 10.1056/NEJMoa2002032.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa2002032</ArticleId><ArticleId IdType="pmc">PMC7092819</ArticleId><ArticleId IdType="pubmed">32109013</ArticleId></ArticleIdList></Reference><Reference><Citation>Overview: COVID-19 Rapid Guideline: Managing the Long-Term Effects of COVID-19: Guidance.  [(accessed on 12 August 2022)].  Available online:  https://www.nice.org.uk/guidance/ng188.</Citation></Reference><Reference><Citation>Loeffelholz M.J., Tang Y.-W. Laboratory Diagnosis of Emerging Human Coronavirus Infections&#x2014;The State of the Art. Emerg. Microbes Infect. 2020;9:747&#x2013;756. doi: 10.1080/22221751.2020.1745095.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/22221751.2020.1745095</ArticleId><ArticleId IdType="pmc">PMC7172701</ArticleId><ArticleId IdType="pubmed">32196430</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou M., Zhang X., Qu J. Coronavirus Disease 2019 (COVID-19): A Clinical Update. Front. Med. 2020;14:126&#x2013;135. doi: 10.1007/s11684-020-0767-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11684-020-0767-8</ArticleId><ArticleId IdType="pmc">PMC7115348</ArticleId><ArticleId IdType="pubmed">32240462</ArticleId></ArticleIdList></Reference><Reference><Citation>Hill E., Mehta H., Sharma S., Mane K., Xie C., Cathey E., Loomba J., Russell S., Spratt H., DeWitt P.E., et al. Risk Factors Associated with Post-Acute Sequelae of SARS-CoV-2 in an EHR Cohort: A National COVID Cohort Collaborative (N3C) Analysis as Part of the NIH RECOVER Program. medRxiv. 2022 doi: 10.1101/2022.08.15.22278603.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2022.08.15.22278603</ArticleId></ArticleIdList></Reference><Reference><Citation>Rauti R., Shahoha M., Leichtmann-Bardoogo Y., Nasser R., Paz E., Tamir R., Miller V., Babich T., Shaked K., Ehrlich A., et al. Effect of SARS-CoV-2 Proteins on Vascular Permeability. eLife. 2021;10:e69314. doi: 10.7554/eLife.69314.</Citation><ArticleIdList><ArticleId IdType="doi">10.7554/eLife.69314</ArticleId><ArticleId IdType="pmc">PMC8545399</ArticleId><ArticleId IdType="pubmed">34694226</ArticleId></ArticleIdList></Reference><Reference><Citation>Theoharides T.C. Could SARS-CoV-2 Spike Protein Be Responsible for Long-COVID Syndrome? Mol. Neurobiol. 2022;59:1850&#x2013;1861. doi: 10.1007/s12035-021-02696-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12035-021-02696-0</ArticleId><ArticleId IdType="pmc">PMC8757925</ArticleId><ArticleId IdType="pubmed">35028901</ArticleId></ArticleIdList></Reference><Reference><Citation>Fern&#xe1;ndez-de-las-Pe&#xf1;as C., Cancela-Cilleruelo I., Rodr&#xed;guez-Jim&#xe9;nez J., G&#xf3;mez-Mayordomo V., Pellicer-Valero O.J., Mart&#xed;n-Guerrero J.D., Hern&#xe1;ndez-Barrera V., Arendt-Nielsen L., Torres-Macho J. Associated-Onset Symptoms and Post-COVID-19 Symptoms in Hospitalized COVID-19 Survivors Infected with Wuhan, Alpha or Delta SARS-CoV-2 Variant. Pathogens. 2022;11:725. doi: 10.3390/pathogens11070725.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/pathogens11070725</ArticleId><ArticleId IdType="pmc">PMC9320021</ArticleId><ArticleId IdType="pubmed">35889971</ArticleId></ArticleIdList></Reference><Reference><Citation>Haroon S., Nirantharakumar K., Hughes S.E., Subramanian A., Aiyegbusi O.L., Davies E.H., Myles P., Williams T., Turner G., Chandan J.S., et al. Therapies for Long COVID in Non-Hospitalised Individuals: From Symptoms, Patient-Reported Outcomes and Immunology to Targeted Therapies (The TLC Study) BMJ Open. 2022;12:e060413. doi: 10.1136/bmjopen-2021-060413.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjopen-2021-060413</ArticleId><ArticleId IdType="pmc">PMC9044550</ArticleId><ArticleId IdType="pubmed">35473737</ArticleId></ArticleIdList></Reference><Reference><Citation>Rivelli A., Fitzpatrick V., Blair C., Copeland K., Richards J. Incidence of COVID-19 Reinfection among Midwestern Healthcare Employees. PLoS ONE. 2022;17:e0262164. doi: 10.1371/journal.pone.0262164.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0262164</ArticleId><ArticleId IdType="pmc">PMC8726474</ArticleId><ArticleId IdType="pubmed">34982800</ArticleId></ArticleIdList></Reference><Reference><Citation>Corral-Gudino L., Del-Amo-Merino M.P., Eiros-Bouza J.M., Garc&#xed;a-Cruces-M&#xe9;ndez J.F., Gonz&#xe1;lez M.D.-G. The Omicron Wave and the Waning of COVID-19 Vaccine Effectiveness. Influence of Vaccine Booster and Age on Confirmed Infection Incidence. Eur. J. Intern. Med. 2022;102:122&#x2013;124. doi: 10.1016/j.ejim.2022.05.025.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ejim.2022.05.025</ArticleId><ArticleId IdType="pmc">PMC9132883</ArticleId><ArticleId IdType="pubmed">35641361</ArticleId></ArticleIdList></Reference><Reference><Citation>Fan Y., Li X., Zhang L., Wan S., Zhang L., Zhou F. SARS-CoV-2 Omicron Variant: Recent Progress and Future Perspectives. Signal Transduct. Target Ther. 2022;7:141. doi: 10.1038/s41392-022-00997-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41392-022-00997-x</ArticleId><ArticleId IdType="pmc">PMC9047469</ArticleId><ArticleId IdType="pubmed">35484110</ArticleId></ArticleIdList></Reference><Reference><Citation>Lauring A.S., Tenforde M.W., Chappell J.D., Gaglani M., Ginde A.A., McNeal T., Ghamande S., Douin D.J., Talbot H.K., Casey J.D., et al. Clinical Severity of, and Effectiveness of MRNA Vaccines against, COVID-19 from Omicron, Delta, and Alpha SARS-CoV-2 Variants in the United States: Prospective Observational Study. BMJ. 2022;376:e069761. doi: 10.1136/bmj-2021-069761.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj-2021-069761</ArticleId><ArticleId IdType="pmc">PMC8905308</ArticleId><ArticleId IdType="pubmed">35264324</ArticleId></ArticleIdList></Reference><Reference><Citation>Bechmann N., Barthel A., Schedl A., Herzig S., Varga Z., Gebhard C., Mayr M., Hantel C., Beuschlein F., Wolfrum C., et al. Sexual Dimorphism in COVID-19: Potential Clinical and Public Health Implications. Lancet Diabetes Endocrinol. 2022;10:221&#x2013;230. doi: 10.1016/S2213-8587(21)00346-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-8587(21)00346-6</ArticleId><ArticleId IdType="pmc">PMC8803381</ArticleId><ArticleId IdType="pubmed">35114136</ArticleId></ArticleIdList></Reference><Reference><Citation>Tenforde M.W., Self W.H., Naioti E.A., Ginde A.A., Douin D.J., Olson S.M., Talbot H.K., Casey J.D., Mohr N.M., Zepeski A., et al. Sustained Effectiveness of Pfizer-BioNTech and Moderna Vaccines Against COVID-19 Associated Hospitalizations Among Adults&#x2014;United States, March&#x2013;July 2021. MMWR Morb. Mortal. Wkly. Rep. 2021;70:1156&#x2013;1162. doi: 10.15585/mmwr.mm7034e2.</Citation><ArticleIdList><ArticleId IdType="doi">10.15585/mmwr.mm7034e2</ArticleId><ArticleId IdType="pmc">PMC8389395</ArticleId><ArticleId IdType="pubmed">34437524</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang C., Wang Y., Li X., Ren L., Zhao J., Hu Y., Zhang L., Fan G., Xu J., Gu X., et al. Clinical Features of Patients Infected with 2019 Novel Coronavirus in Wuhan, China. Lancet. 2020;395:497&#x2013;506. doi: 10.1016/S0140-6736(20)30183-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)30183-5</ArticleId><ArticleId IdType="pmc">PMC7159299</ArticleId><ArticleId IdType="pubmed">31986264</ArticleId></ArticleIdList></Reference><Reference><Citation>Seeni R., Firzli T., Riddle M.S., Krasner C., Ashraf S., Siddiqui F. Using COVID-19 Cycle Threshold and Other Lab Values as Predictors of Hospitalization Need. J. Med. Virol. 2021;93:3007&#x2013;3014. doi: 10.1002/jmv.26835.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.26835</ArticleId><ArticleId IdType="pubmed">33527470</ArticleId></ArticleIdList></Reference><Reference><Citation>Aluru N., Rajyalakshmi B., Reddy P.R. Prognostic Value of &#x201c;Cycle Threshold&#x201d; in Confirmed COVID-19 Patients. Indian J. Crit. Care Med. 2021;25:322&#x2013;326. doi: 10.5005/jp-journals-10071-23765.</Citation><ArticleIdList><ArticleId IdType="doi">10.5005/jp-journals-10071-23765</ArticleId><ArticleId IdType="pmc">PMC7991767</ArticleId><ArticleId IdType="pubmed">33790515</ArticleId></ArticleIdList></Reference><Reference><Citation>Cohen R., Finn T., Babushkin F., Geller K., Alexander H., Shapiro M., Uda M., Mostrchy A.R., Amash R., Shimoni Z., et al. High Rate of Bacterial Respiratory Tract Co-Infections upon Admission amongst Moderate to Severe COVID-19 Patients. Infect. Dis. 2022;54:134&#x2013;144. doi: 10.1080/23744235.2021.1985732.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/23744235.2021.1985732</ArticleId><ArticleId IdType="pmc">PMC8500304</ArticleId><ArticleId IdType="pubmed">34606393</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou F., Yu T., Du R., Fan G., Liu Y., Liu Z., Xiang J., Wang Y., Song B., Gu X., et al. Clinical Course and Risk Factors for Mortality of Adult Inpatients with COVID-19 in Wuhan, China: A Retrospective Cohort Study. Lancet. 2020;395:1054&#x2013;1062. doi: 10.1016/S0140-6736(20)30566-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)30566-3</ArticleId><ArticleId IdType="pmc">PMC7270627</ArticleId><ArticleId IdType="pubmed">32171076</ArticleId></ArticleIdList></Reference><Reference><Citation>Lansbury L., Lim B., Baskaran V., Lim W.S. Co-Infections in People with COVID-19: A Systematic Review and Meta-Analysis. J. Infect. 2020;81:266&#x2013;275. doi: 10.1016/j.jinf.2020.05.046.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jinf.2020.05.046</ArticleId><ArticleId IdType="pmc">PMC7255350</ArticleId><ArticleId IdType="pubmed">32473235</ArticleId></ArticleIdList></Reference><Reference><Citation>Du R.-H., Liang L.-R., Yang C.-Q., Wang W., Cao T.-Z., Li M., Guo G.-Y., Du J., Zheng C.-L., Zhu Q., et al. Predictors of Mortality for Patients with COVID-19 Pneumonia Caused by SARS-CoV-2: A Prospective Cohort Study. Eur. Respir. J. 2020;55:2000524. doi: 10.1183/13993003.00524-2020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/13993003.00524-2020</ArticleId><ArticleId IdType="pmc">PMC7144257</ArticleId><ArticleId IdType="pubmed">32269088</ArticleId></ArticleIdList></Reference><Reference><Citation>Bermejo-Martin J.F., Almansa R., Men&#xe9;ndez R., Mendez R., Kelvin D.J., Torres A. Lymphopenic Community Acquired Pneumonia as Signature of Severe COVID-19 Infection. J. Infect. 2020;80:e23&#x2013;e24. doi: 10.1016/j.jinf.2020.02.029.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jinf.2020.02.029</ArticleId><ArticleId IdType="pmc">PMC7133663</ArticleId><ArticleId IdType="pubmed">32145214</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>